pneumococcal carriage
Inflammation induced by influenza virus impairs innate control of human pneumococcal carriage
42
Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage
12
Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13 valent pneumococcal conjugate vaccination
24
Herd immunity alters the conditions for performing dose schedule comparisons: an individual based model of pneumococcal carriage
10
Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case–control study
14
Pneumococcal carriage among HIV infected children in Accra, Ghana
7
Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children
8
Characterisation of Treg and Th17 cells in Nasopharynx-associated lymphoid tissue and their association with pneumococcal carriage in children and adults
238
Antibodies to Pneumococcal Proteins PhtD, CbpA, and LytC in Filipino Pregnant Women and Their Infants in Relation to Pneumococcal Carriage
8
Experimental Human Pneumococcal Carriage Augments IL-17A-dependent T-cell Defence of the Lung
12
Molecular Epidemiology of Pneumococcal Carriage among Children with Upper Respiratory Tract Infections in Hanoi, Vietnam
6
Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13 valent pneumococcal conjugate vaccination
8
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage
22
Emerging pneumococcal carriage serotypes in a high risk population receiving universal 7 valent pneumococcal conjugate vaccine and 23 valent polysaccharide vaccine since 2001
9
Impact of Experimental Human Pneumococcal Carriage on Nasopharyngeal Bacterial Densities in Healthy Adults
7
Experimental human pneumococcal carriage
216
Maternal Antibodies to Pneumolysin but Not to Pneumococcal Surface Protein A Delay Early Pneumococcal Carriage in High-Risk Papua New Guinean Infants
6
The immunological mechanisms that control pneumococcal carriage
25
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
15
Revisiting Pneumococcal Carriage by Use of Broth Enrichment and PCR Techniques for Enhanced Detection of Carriage and Serotypes
8